DAM
EW icon

Deimos Asset Management’s Edwards Lifesciences EW Stock Holding History

Deimos Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-30,000
Closed -$997K – 21
2016
Q2 		$997K Buy
+30,000
New +$1.03M 0.43% 48

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Deimos Asset Management's EW Position: Q3 2016 in Review

Deimos Asset Management sold out of Edwards Lifesciences (EW) in Q3 2016, closing a stake of 30,000 shares — an estimated $997K sold.

Deimos Asset Management first reported a position in EW in Q2 2016 and held it in 1 quarter. The position peaked at $997K in Q2 2016. 693 funds tracked by Wall St. Rank hold EW as of Q3 2016.

  • Deimos Asset Management reported no remaining Edwards Lifesciences position as of Q3 2016 after selling out during the quarter.
  • Deimos Asset Management sold 30,000 Edwards Lifesciences shares in Q3 2016, an estimated $997K.
  • Deimos Asset Management first reported a position in Edwards Lifesciences in Q2 2016 and held it in 1 quarter.
  • Deimos Asset Management's Edwards Lifesciences position peaked at $997K in Q2 2016.
  • 693 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2016.

Based on Deimos Asset Management's 13F filing for Q3 2016.